Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating JY09 versus dulaglutide as add-on therapy to metformin in adults with type 2 diabetes mellitus; the study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• JY09

Snippet

Sponsor: Beijing Dongfang Biotech Co., Ltd. | Conditions: Type2 Diabetes Mellitus | Phase 3 | Status: ACTIVE_NOT_RECRUITING